Davidson B - Search Results

1

Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas.

Micci F, Panagopoulos I, Thorsen J, Davidson B, Tropé CG, Heim S. Micci F, et al. Among authors: davidson b. PLoS Biol. 2014 Feb 4;12(2):e1001784. doi: 10.1371/journal.pbio.1001784. eCollection 2014 Feb. PLoS Biol. 2014. PMID: 24504521 Free PMC article.

2

Caveolin-1 expression in ovarian carcinoma is MDR1 independent.

Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, Risberg B, Kopolovic J, Kristensen GB, Tropé CG, van de Putte G, Reich R. Davidson B, et al. Am J Clin Pathol. 2002 Feb;117(2):225-34. doi: 10.1309/u40r-1bn4-6kj3-bdg3. Am J Clin Pathol. 2002. PMID: 11863219

3

Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.

Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I. Davidson B, et al. Clin Exp Metastasis. 2002;19(2):135-44. doi: 10.1023/a:1014582911680. Clin Exp Metastasis. 2002. PMID: 11964077

4

Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.

Karbova E, Davidson B, Metodiev K, Tropé CG, Nesland JM. Karbova E, et al. Among authors: davidson b. Int J Surg Pathol. 2002 Jul;10(3):175-80. doi: 10.1177/106689690201000302. Int J Surg Pathol. 2002. PMID: 12232570

5

Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.

Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA. Davidson B, et al. Clin Cancer Res. 2003 Jun;9(6):2248-59. Clin Cancer Res. 2003. PMID: 12796393

6

AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.

Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope' CG, Risberg B, Kopolovic J. Davidson B, et al. Gynecol Oncol. 2003 Aug;90(2):248-57. doi: 10.1016/s0090-8258(03)00321-4. Gynecol Oncol. 2003. PMID: 12893184

7

Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions.

Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Tropé CG, Reich R. Givant-Horwitz V, et al. Among authors: davidson b. Gynecol Oncol. 2003 Oct;91(1):160-72. doi: 10.1016/s0090-8258(03)00434-7. Gynecol Oncol. 2003. PMID: 14529677

8

Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.

Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, Schaefer E, Reich R. Davidson B, et al. Clin Exp Metastasis. 2003;20(7):621-31. doi: 10.1023/a:1027347932543. Clin Exp Metastasis. 2003. PMID: 14669793

9

The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.

Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R. Givant-Horwitz V, et al. Among authors: davidson b. Gynecol Oncol. 2004 May;93(2):517-23. doi: 10.1016/j.ygyno.2004.03.009. Gynecol Oncol. 2004. PMID: 15099972

10

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.

Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC. Davidson B, et al. Cancer. 2004 May 15;100(10):2139-47. doi: 10.1002/cncr.20219. Cancer. 2004. PMID: 15139056 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,484 results

Search Page